Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thierry Vial

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Therapie|June 3, 2005
[Validation of a measurement scale: example of a French Adverse Drug Reactions Preventability Scale]Pascale Olivier, Jacques Caron, Françoise Haramburu, et al.
Therapie|September 25, 2017
[Fibrates and risk of venous thromboembolism: Case/no-case study in French pharmacovigilance database]Xavier Humbert, Charles Dolladille, Marion Sassier, et al.
Therapie|February 17, 2021
Relationship between adverse drug reactions and unlicensed/off-label drug use in hospitalized children (EREMI): A study protocolKim An Nguyen, Yanis Mimouni, Elham Jaberi, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|April 7, 2004
Hidden cardiac lesions and psychotropic drugs as a possible cause of sudden death in psychiatric patients: a report of 14 cases and review of the literatureDominique Frassati, Alain Tabib, Bernard Lachaux, et al.
Thrombosis and Haemostasis|May 30, 2006
Vitamin K antagonists and pregnancy outcome. A multi-centre prospective studyChristof Schaefer, Doreen Hannemann, Reinhard Meister, et al.
Hematological Oncology|October 7, 2017
Delayed methotrexate elimination: Incidence, interaction with antacid drugs, and clinical consequences?Florence Ranchon, Nicolas Vantard, Emilie Henin, et al.
Journal of Clinical Pharmacology|December 17, 2011
Pregnancy outcome following exposure to topical retinoids: a multicenter prospective studyAlice Panchaud, Chantal Csajka, Paul Merlob, et al.
Reproductive Toxicology (Elmsford, N.Y.)|July 1, 2008
The safety of calcium channel blockers during pregnancy: a prospective, multicenter, observational studyCorinna Weber-Schoendorfer, Doreen Hannemann, Reinhard Meister, et al.
BMC Pharmacology & Toxicology|January 15, 2014
Hypersensitivity to oxaliplatin: clinical features and risk factorsMarie Parel, Florence Ranchon, Audrey Nosbaum, et al.
Frontiers in Public Health|December 4, 2023
Prevention and management of health products shortages by the French national agency (ANSM), 10 years of experienceLaëtitia Belgodère, Joseph Emmerich, Nicolas Albin, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Therapie|June 3, 2005
[Validation of a measurement scale: example of a French Adverse Drug Reactions Preventability Scale]Pascale Olivier, Jacques Caron, Françoise Haramburu, et al.
Therapie|September 25, 2017
[Fibrates and risk of venous thromboembolism: Case/no-case study in French pharmacovigilance database]Xavier Humbert, Charles Dolladille, Marion Sassier, et al.
Therapie|February 17, 2021
Relationship between adverse drug reactions and unlicensed/off-label drug use in hospitalized children (EREMI): A study protocolKim An Nguyen, Yanis Mimouni, Elham Jaberi, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|April 7, 2004
Hidden cardiac lesions and psychotropic drugs as a possible cause of sudden death in psychiatric patients: a report of 14 cases and review of the literatureDominique Frassati, Alain Tabib, Bernard Lachaux, et al.
Thrombosis and Haemostasis|May 30, 2006
Vitamin K antagonists and pregnancy outcome. A multi-centre prospective studyChristof Schaefer, Doreen Hannemann, Reinhard Meister, et al.
Hematological Oncology|October 7, 2017
Delayed methotrexate elimination: Incidence, interaction with antacid drugs, and clinical consequences?Florence Ranchon, Nicolas Vantard, Emilie Henin, et al.
Journal of Clinical Pharmacology|December 17, 2011
Pregnancy outcome following exposure to topical retinoids: a multicenter prospective studyAlice Panchaud, Chantal Csajka, Paul Merlob, et al.
Reproductive Toxicology (Elmsford, N.Y.)|July 1, 2008
The safety of calcium channel blockers during pregnancy: a prospective, multicenter, observational studyCorinna Weber-Schoendorfer, Doreen Hannemann, Reinhard Meister, et al.
BMC Pharmacology & Toxicology|January 15, 2014
Hypersensitivity to oxaliplatin: clinical features and risk factorsMarie Parel, Florence Ranchon, Audrey Nosbaum, et al.
Frontiers in Public Health|December 4, 2023
Prevention and management of health products shortages by the French national agency (ANSM), 10 years of experienceLaëtitia Belgodère, Joseph Emmerich, Nicolas Albin, et al.
Pageof 7